Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SightLine Partners is a Minneapolis-based private equity and venture capital firm that specializes in providing secondary liquidity and growth capital to late-stage companies in the healthcare sector. The firm manages the SightLine Funds, which primarily target investments in medical devices, diagnostics, and healthcare information technology. SightLine typically acquires interests in companies that have already achieved significant clinical or regulatory milestones, such as FDA approval or CE Mark, helping to bridge the gap to an exit or further commercial expansion. Their portfolio includes numerous successful medical technology companies that have reached commercialization or been acquired by major industry players.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SightLine Funds.